저자의 연구 키워드

저자의 연구 키워드

#공존질환

#노인 환자

#뉴로피드백

#면시간

#부모양육태도

#부모역할만족도

#부프로피온

#선별검사

#성별차이

#소아

#수면문제

#수면시간

#신뢰도

#아리피프라졸

#연령별 차이

#우울장애

#우울증

#우울증.

#우울증상

#유병률

#인지행동요법

#임상진료지침

#임상진료지침우울증

#자살경향성

#자살위험도

#정반응 소요시간

#정반응율

#정서인식

#정신장애

#정신장애 진단선별질문지

#주요우울장애·MINI-Plus·공존질환·불안장애.

#주요우울증

#주의력결핍 과잉행동장애

#주의집중력

#진단

#진단도구

#체질량지수

#치료순응도

#타당도

#평가

#핵심증상

#혼합형

#환경적 요인

#ADHD

#ADHD· Intelligence level· Executive function.

#Adolescent.

#Adolescents

#Adverse effect

#Age difference

#Agreement

#Algorithm

#Algorithm.

#Aripiprazole

#Aripiprazole ㆍBupropion ㆍTreatment resistant depression ㆍFemale depression ㆍAnxiety ㆍ Somatic symptom.

#Attention

#Attention deficit hyperactivity disorder

#BDI-Ⅱ

#Body Mass Index

#Bupropion

#CBT

#Child

#Children

#Clinical practice guideline

#Combined type

#Comorbid physical iIlness

#Comorbid physical illness

#Comorbidity

#Core symptoms

#Decision making speed

#Depression

#Depression Rating Scales

#Depression.

#Depressive disorder

#Depressive symptoms

#Diagnosis

#Diagnostic instrument

#Elderly

#Emotional recognition

#Environmental factor

#Evaluation

#Female

#Female and elderly.

#Hit ratio

#Kinds of use.

#Korean Medication Algorithm

#Korean Medication Algorithm Project

#Korean Medication Algorithm Project for Depressive Disorder 2021

#Major depressive disorder

#Major depressive disorder ㆍMINI-Plus ㆍComorbidity ㆍAnxiety disorder.

#Metadate-CD.

#Methylphenidate

#Neurofeedback

#Non-pharmacological biological treatments

#Non-pharmacological biological treatments.

#OROS Methylphenidate

#OROS-MPH

#Parent satisfaction

#Parenting

#Persistent depressive disorder

#Persisting depressive disorder

#Pharmacotherapy

#Prevalence

#Psychiatric Diagnostic Screening Questionnaire

#Psychiatric disorder

#Purpose of use

#Reliability

#Safety

#Satisfaction

#Screening

#Sex difference

#Sleep duration

#Sleep problem

#Subtype

#Subtype.

#Suicidal risk

#Suicidality

#The adult patients

#Treatment Adherence

#Treatment resistant depression

#Treatment resistant depression.

#Validity